Causaly today announced new scientific AI agents that provide research teams with the industry's most comprehensive ...

On the same day, Novo Nordisk's stock price fell by 1.34%, with a market capitalization of approximately 2 trillion kroner (approximately 436 trillion won). SAP logo. /Courtesy of Reuters SAP is a ...

St. Christopher's Hospital for Children, a nationally recognized leader in pediatric health care, medical training and research, today kicked off a celebration of its 150th anniversary. The milestone, ...

Getac Technology Corporation (Getac), a leading provider of rugged computing and mobile video solutions, today announced that ...

Novo Nordisk (NVO) presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic injection 1 mg in adults ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

The two market leaders are targeting new obesity alternatives in their pipelines with an eye toward a triple threat.

As Novo Nordisk A/S shares head for their worst month in more than two decades, the days when the Danish drugmaker was valued at more than $600 billion are becoming a distant memory.

Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the ...

Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy ...